Archive:
Oct 23, 2023, 12:00 AM
Startup Spotlight- DUB Biologics' new therapy for corneal scarring could revolutionize treatment
October
23,
2023
DUB Biologics is developing a self-delivery siRNA that prevents scarring and inflammation by targeting knockdown of USP10, initially in corneal opacification applications.
Dr.
Read More »